Bio-Rad, Ciphergen, Illumina, Erasmus MC, Harvard Medical School, BioForce Nanosciences | GenomeWeb
Bio-Rad Closes Acquisition of Ciphergen's Proteomics Tools Division
 
Bio-Rad Laboratories has finalized its purchase of Ciphergen Biosystems’ proteomics tools business, the company said this week.
 
The companies had expected the deal, which was announced in August, to close November 1, but it was delayed after receiving shareholder approval in late October.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.